Vineet Laboratories Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 43,169 shares,. Its Average Traded Price (ATP) is ₹35.95, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹36.19.
Vineet Laboratories has an upper circuit limit of ₹37.57 and a lower circuit limit of ₹34.01. The total value traded stands at ₹15.52 L, and the delivery percentage for the day is 58.34%.
The stock is currently traded with a market lot size of 1. Vineet Laboratories also offers a dividend yield of 0%.
Vineet Laboratories Share Price Chart
Vineet Laboratories Share Key Metrics
Volume
43169.00
Market Cap
68.74 CR
LTQ@LTP
1@36.19
ATP
35.95
Var Margin
25 %
Circuit Range
34.01-37.57
Delivery %
58.34 %
Value
15.52 L
ASM/GSM
No
Market Lot
1
Vineet Laboratories Resistance and Support
Pivot 36.31
Resistance
First Resistance
37.12
Second Resistance
38.46
Third Resistance
39.27
Support
First Support
34.97
Second Support
34.16
Third Support
32.82
Vineet Laboratories Shareholding Pattern
View More- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Vineet Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-25 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-27 | Right issue of Equity Shares |
| 2025-11-08 | Quarterly Results |
| 2025-10-23 | Quarterly Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
| Rights Date | Ratio | |
|---|---|---|
| 2025-12-23 | 13:12 | View More |
Vineet Laboratories News
Vineet Laboratories Ltd - 543298 - Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, August 25, 2026 As Required Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Vineet Laboratories' Board approved audited Q4 and FY26 standalone financial results on August 25, 2026. The company reported a net profit of ₹1.11 crore for FY26, a substantial improvement from the ₹20.19 crore net loss in FY25.
Aug 25 2026 19:12:33
Vineet Laboratories Ltd - 543298 - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Vineet Laboratories will hold a Board Meeting on August 25, 2026, to consider and approve its audited standalone financial results for the fourth quarter and the financial year ended March 31, 2026.
Aug 20 2026 18:23:41
Vineet Laboratories Ltd - 543298 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Vineet Laboratories' monitoring agency reported inadvertent utilization of Rs. 25.91 lakh from rights issue proceeds for non-approved purposes during Q1 FY27, which was later reversed. The report also indicated delays in the implementation of projects funded by the rights issue due to finalization issues.
Aug 14 2026 18:59:34
Vineet Laboratories Management
| Name | Position |
|---|---|
| Ramesh Bandari | Company Secretary & Compliance Officer |
| Dilip Vishnu Acharekar | Chairman |
Vineet Laboratories Similar Stocks
Vineet Laboratories FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in VINEETLAB
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC